11Beta-hydroxysteroid-dehydrogenase isoforms: tissue distribution and implications for clinical medicine

Eur J Clin Invest. 2000 Dec:30 Suppl 3:21-7. doi: 10.1046/j.1365-2362.2000.0300s3021.x.

Abstract

11Beta-hydroxylation is essential for glucocorticoid and mineralocorticoid activity of a steroid. The enzyme catalyzing this reaction is termed 11beta-hydroxysteroid-dehydrogenase (11beta-HSD). Two isoenzymes of 11beta-HSD have been characterized in human tissues. Whereas 11beta-HSD-I works mainly as a reductase, 11beta-HSD-II only functions as an oxidizing (inactivating) enzyme for physiological glucocorticoids. Thus, the tissue distribution of both enzymes plays a crucial role for the specific glucocorticoid status of an organ. This review summarizes our knowledge of tissue distribution of both 11beta-HSD isoenzymes, their physiological function and pathophysiological role in certain clinical abnormalities, and their relevance to the metabolism of synthetic glucocorticoid and mineralocorticoid compounds.

Publication types

  • Review

MeSH terms

  • 11-beta-Hydroxysteroid Dehydrogenase Type 2
  • Glucocorticoids / metabolism
  • Humans
  • Hydroxysteroid Dehydrogenases / analysis*
  • Hydroxysteroid Dehydrogenases / physiology
  • Xenobiotics / metabolism

Substances

  • Glucocorticoids
  • Xenobiotics
  • Hydroxysteroid Dehydrogenases
  • 11-beta-Hydroxysteroid Dehydrogenase Type 2
  • HSD11B2 protein, human